Nova Patents
AT297767T

Metallic stent which is degradable in vivo

Abstract

A medical implant made of metal is claimed where the metal is degradable in vivo by corrosion. - Preferably the metal is analloy whose main component is an alkali (ne earth) metal, Fe, Zn or Al, especially Mg, Fe or Zn, and whose subsidiary component is Mn, Co, Ni, Cr, Cu, Cd, Pb, Sn, Th, Zr, Ag, Au, Pd, Pt, Si, Ca, Li, aluminum, and Zn and/or Fe. The alloys especially comprise (a) 50-98 (preferably 55-65) % Mg, 0-40 (preferably 30-40) % Li and 0-5% other metals; (b) 88-99% Fe, 0.1-4% Cr, 0.1-3.5% Ni and up to 5% other metals;or (c) 90-96% Fe, 3-6% Cr, 1-3% Ni and 0-5% other metals.

Term

Term ended

Expired 17 July 2018, 8.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

35 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
19731021GermanyA

Members35

Family members, oldest first
DocumentOfficeKind
DE19731021A1GermanyA1
WO9903515A2World Intellectual Property Organization (WIPO)A2
AU9154198AAustraliaA
EP0923389A2European Patent Office (EPO)A2
WO9903515A3World Intellectual Property Organization (WIPO)A3
IL129065D0IsraelD0
JP2001511049AJapanA
US2002004060A1United States of AmericaA1
EP0923389A3European Patent Office (EPO)A3
EP1270023A2European Patent Office (EPO)A2
EP0923389B1European Patent Office (EPO)B1
AT236667TAustriaT
ATE236667T1AustriaT1
DE59807846D1GermanyD1
EP1270023A3European Patent Office (EPO)A3
ES2200368T3SpainT3
EP1270023B1European Patent Office (EPO)B1
EP1552856A1European Patent Office (EPO)A1
AT297767TThis recordAustriaT
ATE297767T1AustriaT1
DE59812873D1GermanyD1
DK1270023T3DenmarkT3
PT1270023EPortugalE
ES2243635T3SpainT3
IL129065AIsraelA
IL172424AIsraelA
JP2009297537AJapanA
US7879367B2United States of AmericaB2
JP2011031063AJapanA
US2011251669A1United States of AmericaA1
US2011301694A1United States of AmericaA1
EP1270023B2European Patent Office (EPO)B2
JP5352776B2JapanB2
US8771751B2United States of AmericaB2
EP1552856B1European Patent Office (EPO)B1